ArticleChinese clinical oncology2017

PARP inhibitor and platinum agent in triple negative breast cancer: utilizing innovative trial design to bring together something "new" and something "old".

Priyanka SharmaPubMed ↗Publisher ↗

No numbers read from the abstract.